Rivastigmine

Classification

1. Anatomical main groupNNervous system
2. Therapeutic subgroupN06
3. Pharmacological subgroupN06D
4. Chemical subgroupN06DA
5. Chemical substanceN06DA03Rivastigmine

Where it is registered

Each register with its number of medicines and a few of them.

• 🇪🇸Spain

  AEMPS · 138 medicines

  • Alzerta 13,3 MG/24 H Parches Transdermicos Efg19,2 mg · parche transdérmico · Esteve Pharmaceuticals S.A.
  • Alzerta 4,6 MG/24 H Parches Transdermicos Efg6,9 mg · parche transdérmico · Esteve Pharmaceuticals S.A.
  • Alzerta 9,5 MG/24 H Parches Transdermicos Efg13,8 mg · parche transdérmico · Esteve Pharmaceuticals S.A.
  • Alzerta Dos Por Semana 4,6 MG/24 H Parches Transdermicos25,92 mg · parche transdérmico · Esteve Pharmaceuticals S.A.
  Show all 138

• 🇨🇦Canada